Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06385535 · ClinicalTrials.gov registry record · NA

Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder

A NA study of Tourette Syndrome and Tic Disorders, sponsored by University of Utah.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06385535: Recruiting NA study of Tourette Syndrome and Tic Disorders, sponsored by University of Utah.

NCT06385535 is a NA study of Tourette Syndrome and Tic Disorders that is actively recruiting participants, run by University of Utah. The registered enrollment target is 12 participants, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06385535, a NA study of Tourette Syndrome and Tic Disorders, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical study is to learn more about the timing of tics (sudden, fast movements and sounds that people do and make without meaning to) in people who have multiple tics that have been going on for more than one year. The main questions it aims to answer are: 1. See whether a tic's timing is related to other characteristics of the tic, like how long it has been happening and how well the person can control/stop that tic 2. See whether the timing of a tic can tell us how well the person can control/stop that tic 3. See whether tic treatment changes the timing of tics, and if the timing of a tic has anything to do with how well treatment will work to stop it Participants will meet with a study researcher to learn more about the study, ask questions, and decide whether or not they would like to be involved. If they decide to do the study, they will meet with the researcher 6 times: 1. During the first visit, the study researcher will ask questions about the participant's life, tics, and other psychological symptoms. The researcher will watch the participant's tics for 10 minutes. The participant will do a computer task where they follow instructions to tic or not tic. 2. During the second visit, the study researcher will treat one of the participant's tics. 3. During the third visit, the study researcher will treat another one of the participant's tics. 4. During the fourth visit, the study researcher will treat another one of the participant's tics. 5. During the fifth visit, the study researcher will treat another one of the participant's tics. 6. During the sixth visit, the study researcher will ask questions about the participant's tics and other psychological symptoms. The participant will do a computer task where they follow instructions to tic or not tic.

Interventions

  • BEHAVIORAL Habit Reversal Training (HRT)

Study Locations (1)

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-04-04
Est. Completion 2024-12
Phase NA
University of Utah

818 total trials

What NCT06385535 shows while recruiting

NCT06385535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 86-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (86% lower).

The record links to 8 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Habit Reversal Training (HRT) is the first listed.

NCT06385535 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT06385535 about?

NCT06385535 is a clinical study titled "Clinical Characteristics and Temporal Properties of Individual Tics in Persistent Tic Disorder". The goal of this clinical study is to learn more about the timing of tics (sudden, fast movements and sounds that people do and make without meaning to) in people who have multiple tics that have been going on for more than one year. The main questions it aims to answer are: 1. See whether a tic's ...

What is the current status of trial NCT06385535?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-04-04. Estimated completion is 2024-12.

What conditions does trial NCT06385535 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tic Disorders, Tourette Syndrome in Adolescence, Tics, Tourette Syndrome in Children.

What interventions are being tested in trial NCT06385535?

The interventions under investigation include: Habit Reversal Training (HRT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06385535?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06385535 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06385535's enrollment target sits among peer trials

12 30th of 33 higher than 3 of 33 other Tourette Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tourette Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06385535, the US trial registry maintained by the National Library of Medicine. NCT06385535 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.